Alnylam Gets VIP Status as the FDA Slaps Breakthrough Tag on Patisiran Post author:Sam Post published:November 19, 2017 Post category:BioPharma The company is weeks away from completing its rolling NDA for Patisiran. Source: BioSpace You Might Also Like Troubled Dimension Therapeutics Sold in All-Stock Deal August 24, 2017 Flexion Eyes Creation of 100 New Sales Jobs to Sell Just-Approved Osteoarthritis Drug October 10, 2017 Patient Death Forces Alnylam to Suspend Dosing in Hemophilia Trial, Stock Plunges September 6, 2017
Flexion Eyes Creation of 100 New Sales Jobs to Sell Just-Approved Osteoarthritis Drug October 10, 2017
